StonvexLoading…
StonvexStonvexStonvexCore line items from HIG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-27 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $7.47B | $392.00M | $1.51B | $1.12B | $732.00M |
Operating Income | Not available | $1.06B | $4.76B | $3.35B | $2.03B |
Net Income | Not available | $856.00M | $3.84B | $2.71B | $1.63B |
EPS (Diluted) | $3.35 | $3.04 | $13.32 | $9.34 | $5.58 |
Total Assets | Not available | $86.32B | $86.00B | $85.00B | $83.64B |
Total Liabilities | Not available | $67.43B | $67.02B | $66.55B | $66.12B |
Cash & Equivalents | Not available | $220.00M | $177.00M | $206.00M | $219.00M |
Free Cash Flow OCF − CapEx | Not available | $1.01B | $5.75B | $3.99B | $2.20B |
Shares Outstanding | Not available | 279.90M | 286.50M | 287.80M | 289.20M |